To view this email as a web page, click here

   Home

Subscribe

Advertise

 

 

 

 

May 12, 2020___

Today's Rundown

Featured Story

Gilead inks deals with generics makers to supply COVID-19 therapy remdesivir for 127 countries

After scoring an early authorization for its COVID-19 therapy remdesivir, Gilead Sciences has been on the hunt for manufacturing partners to help boost production for the in-demand drug. Through a series of licensing agreements, Gilead has taken the first steps to build that network. 

Top Stories

With 'multiple shots on goal,' NIAID director Anthony Fauci is ‘cautiously optimistic’ about COVID-19 vaccine success

With eight COVID-19 vaccines in human testing and headlines touting their progress each day, a leading U.S. health official voiced some optimism about one or more of them working.

Primary care doctors fear delayed care will lead to serious illnesses, death

More than a third of primary care clinicians fear their patients will die because of delayed care during the COVID-19 pandemic. Clinicians predict primary care will be overwhelmed with pent-up demand, and the majority believe that some of their patients will experience avoidable illnesses, both due to diverted or avoided care, according to a new survey.

UnitedHealth Group has paid out $23.8M in emergency child care benefits due to COVID-19. Here's why

UnitedHealth Group has launched a new program for its employees that will reimburse them for emergency child care to the tune of $100 per day. 

Moderna nabs FDA fast-track tag for its COVID-19 vax

In what will be of little surprise to anyone, the FDA has hitched its fast-track tag to Moderna’s speedy attempt at an mRNA COVID-19 vaccine.

Portraits in Healthcare: 'The family was asking us to … hold her hand so their mother wouldn't be alone as she passed'

At UPMC Presbyterian, Mary McFarland, R.N., was part of a team that worked to convert an ICU unit into the hospital’s first dedicated COVID-19 unit. She shares the moments that have stayed with her during the past two months of treating COVID-19 patients.

Healthcare roundup: Dems want to give providers $100B; BCBSA finds millennials, Gen Zers taking to telehealth

FierceHealthcare's ongoing coverage of how the coronavirus is impacting the healthcare industry.

Regeneron CEO: Manufacturing not up to snuff for COVID-19 vaccines, therapies

Regeneron has been at the forefront of the COVID-19 fight for months with partnered med Kevzara in clinical trials and an antibody cocktail in development. But success in the clinic means nothing if drugmakers can't produce a therapy or vaccine fast enough—and Regeneron's helmsman is sounding the alarm.

LabCorp, Quest broaden availability of COVID-19 tests nationwide

The U.S. clinical testing giants Quest Diagnostics and LabCorp are broadening the availability of their COVID-19 diagnostic tests, opening up their use nationwide.

Here's a look at salaries of U.S. front-line workers in COVID-19 fight compared to the rest of the world

U.S. healthcare workers on the front lines of fighting COVID-19 are among the top paid in the world compared to other major developed nations, according to a new study released this week.